Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) concluded the trading at $484.93 on Wednesday, June 04 with a fall of -0.60% from its closing price on previous day. Company’s P/E ratio for the trailing 12 months is 12.34. Considering stock’s 52-week price range provides that REGN hit a
Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) traded at $490.28 at close of the session on Friday, May 30 and made a downward move of -19.01% on its previous day’s price. Regeneron Pharmaceuticals, Inc has a market cap of $52.93 billion and is expected to release its quarterly
Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) price on Friday, May 23, fall -1.43% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $588.34. A look at the stock’s price movement, the close in the last trading session was $596.85. The
Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) shares, rose in value, with the stock price down by -5.07% to the previous day’s close as strong demand from buyers drove the stock to $532.50. Actively observing the price movement in the recent trading, the stock is buoying the session
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.